Nurexone Biologic Inc
from OTCQB Podcast Hosted by OTC Markets Group
Nurexone Biologic Inc (OTCQB: NRXBF) is a TSXV, OTCQB, and Frankfurt-listed biotech company focused on developing regenerative exosome-based therapies for central nervous system injuries. Lior Shaltiel, CEO of Nurexone Biologic, joins us today to share and explain Nurexone's innovative and promising research on its lead candidate, XOP10. View Podcast Transcript
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 12 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on July 7, 2025.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.